Hafler DA - Search Results

1

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.

De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. De Jager PL, et al. Among authors: hafler da. Neurology. 2008 Mar 25;70(13 Pt 2):1113-8. doi: 10.1212/01.wnl.0000294325.63006.f8. Epub 2008 Feb 13. Neurology. 2008. PMID: 18272866

2

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Brod SA, al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL. Brod SA, et al. Among authors: hafler da. Ann Neurol. 1991 Jun;29(6):615-22. doi: 10.1002/ana.410290608. Ann Neurol. 1991. PMID: 1716432

3

Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis.

Lee SJ, Wucherpfennig KW, Brod SA, Benjamin D, Weiner HL, Hafler DA. Lee SJ, et al. Among authors: hafler da. Ann Neurol. 1991 Jan;29(1):33-40. doi: 10.1002/ana.410290109. Ann Neurol. 1991. PMID: 1847614

4

Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.

Chofflon M, Weiner HL, Morimoto C, Hafler DA. Chofflon M, et al. Among authors: hafler da. Ann Neurol. 1989 May;25(5):494-9. doi: 10.1002/ana.410250512. Ann Neurol. 1989. PMID: 2528316

5

Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.

Carter JL, Hafler DA, Dawson DM, Orav J, Weiner HL. Carter JL, et al. Among authors: hafler da. Neurology. 1988 Jul;38(7 Suppl 2):9-14. Neurology. 1988. PMID: 2838768

6

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.

Chofflon M, Weiner HL, Morimoto C, Hafler DA. Chofflon M, et al. Among authors: hafler da. Ann Neurol. 1988 Aug;24(2):185-91. doi: 10.1002/ana.410240203. Ann Neurol. 1988. PMID: 2972249

7

Immunosuppression with monoclonal antibodies in multiple sclerosis.

Hafler DA, Weiner HL. Hafler DA, et al. Neurology. 1988 Jul;38(7 Suppl 2):42-7. Neurology. 1988. PMID: 3260356

8

Immunotherapy of multiple sclerosis.

Weiner HL, Hafler DA. Weiner HL, et al. Among authors: hafler da. Ann Neurol. 1988 Mar;23(3):211-22. doi: 10.1002/ana.410230302. Ann Neurol. 1988. PMID: 3288084 Review.

9

Immunologic mechanisms and therapy in multiple sclerosis.

Hafler DA, Weiner HL. Hafler DA, et al. Immunol Rev. 1995 Apr;144:75-107. doi: 10.1111/j.1600-065x.1995.tb00066.x. Immunol Rev. 1995. PMID: 7590822 Review. No abstract available.

10

Therapy for multiple sclerosis.

Weiner HL, Hohol MJ, Khoury SJ, Dawson DM, Hafler DA. Weiner HL, et al. Among authors: hafler da. Neurol Clin. 1995 Feb;13(1):173-96. Neurol Clin. 1995. PMID: 7739502 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters